Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 2:351:h4984.
doi: 10.1136/bmj.h4984.

Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study

Mary E Tinetti  1 , Gail McAvay  2 , Mark Trentalange  2 , Andrew B Cohen  2 , Heather G Allore  2
Affiliations

Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study

Mary E Tinetti et al. BMJ. .

Abstract

Objective: To estimate the association between guideline recommended drugs and death in older adults with multiple chronic conditions.

Design: Population based cohort study.

Setting: Medicare Current Beneficiary Survey cohort, a nationally representative sample of Americans aged 65 years or more.

Participants: 8578 older adults with two or more study chronic conditions (atrial fibrillation, coronary artery disease, chronic kidney disease, depression, diabetes, heart failure, hyperlipidemia, hypertension, and thromboembolic disease), followed through 2011.

Exposures: Drugs included β blockers, calcium channel blockers, clopidogrel, metformin, renin-angiotensin system (RAS) blockers; selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs); statins; thiazides; and warfarin.

Main outcome measure: Adjusted hazard ratios for death among participants with a condition and taking a guideline recommended drug relative to participants with the condition not taking the drug and among participants with the most common combinations of four conditions.

Results: Over 50% of participants with each condition received the recommended drugs regardless of coexisting conditions; 1287/8578 (15%) participants died during the three years of follow-up. Among cardiovascular drugs, β blockers, calcium channel blockers, RAS blockers, and statins were associated with reduced mortality for indicated conditions. For example, the adjusted hazard ratio for β blockers was 0.59 (95% confidence interval 0.48 to 0.72) for people with atrial fibrillation and 0.68 (0.57 to 0.81) for those with heart failure. The adjusted hazard ratios for cardiovascular drugs were similar to those with common combinations of four coexisting conditions, with trends toward variable effects for β blockers. None of clopidogrel, metformin, or SSRIs/SNRIs was associated with reduced mortality. Warfarin was associated with a reduced risk of death among those with atrial fibrillation (adjusted hazard ratio 0.69, 95% confidence interval 0.56 to 0.85) and thromboembolic disease (0.44, 0.30 to 0.62). Attenuation in the association with reduced risk of death was found with warfarin in participants with some combinations of coexisting conditions.

Conclusions: Average effects on survival, particularly for cardiovascular study drugs, were comparable to those reported in randomized controlled trials but varied for some drugs according to coexisting conditions. Determining treatment effects in combinations of conditions may guide prescribing in people with multiple chronic conditions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

None
Fig 1 Adjusted hazard ratios of death associated with guideline recommended cardiovascular drugs for older adults with chronic conditions. AF=atrial fibrillation; CAD=coronary artery disease; DEP=depression; DM=diabetes; HF=heart failure; HL=hyperlipidemia; HTN=hypertension. Hazard ratios are adjusted for the covariates described in the Methods section,as well as number of drugs other than the study drugs, and all coexisting study conditions and drugs
None
Fig 2 Adjusted hazard ratios of death associated with commonly used guideline recommended drugs for older adults with chronic conditions. AF=atrial fibrillation; CAD=coronary artery disease; DEP=depression; DM=diabetes; HF=heart failure; HL=hyperlipidemia; HTN=hypertension; SSRIs= selective serotonin reuptake inhibitors; SNRIs=serotonin norepinephrine reuptake inhibitors. Hazard ratios are adjusted for the covariates described in the Methods section as well asnumber of drugs other than the study drug and all coexisting study conditions and drugs
See this image and copyright information in PMC

Comment in

References

    1. Gorina Y, Lentzer H. Multiple causes of death in old age. Aging Trends 2008;(9):1-9. - PubMed
    1. National Center for Health Statistics. Mortality data, multiple-cause-of-death public-use data files. 2015. www.cdc.gov/nchs/data_access/VitalStatsOnline.htm#Mortality_Multiple.
    1. Hoyert DL, Xu JQ. Deaths: preliminary data for 2011. National Vital Statistics Reports; Vol 61 No 6. National Center for Health Statistics; 2012. - PubMed
    1. Tinetti ME, McAvay G, Murphy T, Allore H, Gross, C, Lin H. Contribution of individual diseases to death in older adults with multiple diseases. J Am Geriatr Soc 2012;60:1448-56. - PMC - PubMed
    1. Tinetti ME, McAvay G, Chang SS, et al. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc 2011;59:1686-91. - PMC - PubMed

Publication types